Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.-论文-万方医学网

作者： Jeffrey,Wojton ^[1] ; Zhengtao,Chu ; Haritha,Mathsyaraja ; Walter H,Meisen ; Nicholas,Denton ; Chang-Hyuk,Kwon ; Lionel Ml,Chow ; Mary,Palascak ; Robert,Franco ; Tristan,Bourdeau ; Sherry,Thornton ; Michael C,Ostrowski ; Balveen,Kaur ; Xiaoyang,Qi

作者单位： Dardinger Laboratory for Neuro-oncology and Neurosciences, Department of Neurological Surgery, The Ohio State University Medical Center, Columbus, Ohio 43210, USA. ^[1]

主题词血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);抗肿瘤药(Antineoplastic Agents);血脑屏障(Blood-Brain Barrier);脑肿瘤(Brain Neoplasms);细胞低氧(Cell Hypoxia);细胞系, 肿瘤(Cell Line, Tumor);细胞膜(Cell Membrane);疾病模型, 动物(Disease Models, Animal);女(雌)性(Female);胶质母细胞瘤(Glioblastoma);人类(Humans);男(雄)性(Male);小鼠(Mice);纳米粒子(Nanoparticles);新生血管化, 生理性(Neovascularization, Physiologic);磷脂酰丝氨酸类(Phosphatidylserines);重组蛋白质类(Recombinant Proteins);Saposin蛋白质类(Saposins);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)

DOI 10.1038/mt.2013.114

PMID 23732993

发布时间 2021-10-21

检索历史清除

Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.

Molecular therapy

相似文献

Molecular therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Systemic delivery of SapC-DOPS has antiangiogenic and antitumor effects against glioblastoma.

Molecular therapy

相似文献

Molecular therapy

相关期刊

检索历史清除